PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large. Braun Medical, Inc.

Education 52

Education Marketing Media Biopharma 52

PM360

AUGUST 24, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B.

Marketing 52

Marketing Education Media Healthcare 52

Pharma Marketing Network

JANUARY 12, 2023

She has been responsible for overseeing the full lifecycle of product portfolios, from discovery and development to commercialization and manufacturing. The Kite team now includes more than 4,000 employees dedicated to all aspects of cell therapy from business development and R&D to commercial and manufacturing.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Clarivate

MAY 24, 2022

Approval pathways have been established that allow manufacturers to bring innovative therapies to market without conducting trials in Mainland China, provided the safety and efficacy of the drugs have been demonstrated through real world data (RWD) in other markets. Multinational pharmas seek entry for their products.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Pharmaceutical Technology

OCTOBER 27, 2022

The increasing regulation of biotech and manufacturing deals in the US could prompt foreign companies such as Chinese contract development and manufacturing organisations (CDMOs) to seek alternative targets in Europe or elsewhere. There are already nine Chinese-based companies with 14 US contract manufacturing facilities.

Manufacturing 106

Manufacturing Biopharma Government Pharma 106

European Pharmaceutical Review

OCTOBER 2, 2023

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. CPHI creates connections and inspires partnerships across the global pharma community. CPHI creates connections and inspires partnerships across the global pharma community.

Manufacturing 97

Manufacturing Pharma Engineering Networking 97

Pharmaceutical Technology

MARCH 22, 2023

The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Chromatography and clarification play vital parts in biopharma manufacturing, yet there is room for improvement in processes to eliminate inefficiencies and increase yield.

Biopharma 52

Biopharma Manufacturing Engineering Specialization 52

PM360

SEPTEMBER 15, 2022

med info or case managers) for consumers to contact the manufacturer and ask questions. Empathy needs to be a core strategic imperative for pharma brands. In order to improve patient inclusivity in clinical trials, the biopharma industry must incorporate DEI in all processes. This is a tangible human challenge.

Patients 98

Patients Healthcare Healthcare Marketing 98

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT trials operate with much lower volumes of manufactured final product. CGT have highly unique and specialized manufacturing processes.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Pharmaceutical Technology

AUGUST 26, 2008

As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines. It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals.

Manufacturing 52

Manufacturing Pharmaceutical Biopharma Medicine 52

Clarivate

MAY 24, 2023

With gene therapies, like any specialized treatment, payers are going to be very stringent in making sure patients meet the criteria for treatment, given the cost they’re carrying,” said Kiernan. Payers are also eyeing a variety of stringent utilization management measures to prevent unnecessary care and rein in costs.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52